# Consolidation Therapy With Cladribine in Relapsing Multiple Sclerosis Patients

> **NCT06854094** · — · ACTIVE_NOT_RECRUITING · sponsor: **Ente Ospedaliero Cantonale, Bellinzona** · enrollment: 70 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06854094
- **Lead sponsor:** Ente Ospedaliero Cantonale, Bellinzona
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-10-03
- **Primary completion:** 2026-12
- **Final completion:** 2028-12
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06854094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06854094, "Consolidation Therapy With Cladribine in Relapsing Multiple Sclerosis Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06854094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*